Media

Filter by Category

All Blog News Newsletters Podcasts Presentations Press Releases Publications Videos

Filter by Program

Filter by Date

June 13, 2017

C-Path and CDISC Announce Public Review Period for Duchenne Therapeutic Area Standard

June 13, 2017 TUCSON, Ariz., and AUSTIN, Texas – June 13, 2017 – The Clinical Data Interchange Standards Consort

June 12, 2017

Regulatory Science in Neonates: A Framework That Supports Evidence-Based Drug Therapy

June 9, 2017

The FDA is Listening: Integrating the Voice of the Patient in Drug Development for Parkinson’s and Huntington’s Diseases

June 9, 2017

The Critical Path for Parkinson’s Consortium: Understanding Motor Disease Progression Through Quantitative Medicine

June 9, 2017

Global Regulatory Agencies Support the Use of Dopamine Transporter Neuroimaging for Subject Selection in Clinical Trials Targeting Early Stage Parkinson’s Disease

June 6, 2017

Selection of and Evidentiary Considerations for Wearable Devices and Their Measurements for Use in Regulatory Decision Making: Recommendations from the ePRO Consortium

This webinar provides a recommended framework for the selection and evaluation of wearable devices and their measurements for use

May 31, 2017

Development of a Harmonized Patient-Reported Outcome Questionnaire to Assess Myelofibrosis Symptoms in Clinical Trials

May 24, 2017

INC News – Issue #3

May 22, 2017

miR-122 An Exploratory Biomarker of Liver Injury: An Industry Perspective on the State of the Science and Experiences Pre-Clinically and Clinically

The Critical Path Institute’s Predictive Safety Testing Consortium (PSTC) hosted a webinar focused on providing an industry pers

May 18, 2017

Enabling Integration of Alzheimer Disease (AD) Prevention Study Data by Application of CDISC Standards: Extension to Biometric Monitoring Device (BMD) Assessments

Arnerić, S.P., et al.; “Enabling Integration of Alzheimer Disease (AD) Prevention Study Data by Application of CDISC Standards:

Previous8889 90...133 Next